Sale!
Semaglutide 10mg research peptide vial with lyophilized powder for laboratory use
NuGenia Research Semaglutide 20mg peptide vial – research grade lyophilized peptide, 99% purity
NuGenia Logics > Research Peptides > NuGenia Logics > Semaglutide (10mg / 20mg) – GLP-1 Receptor Agonist Peptide

Semaglutide (10mg / 20mg) – GLP-1 Receptor Agonist Peptide

Price range: $59 through $89

SKU: N/A Categories: , , , Tags: , , , , , Brand:

IN STOCK – SHIPS TODAY

★★★★★
4.9 (74)

Semaglutide is a GLP-1 receptor agonist — an acylated 31-amino-acid analog of human GLP-1 — studied in glucoregulation and energy-metabolism research. Available in 10mg and 20mg vials, ≥99% purity, third-party tested. For research use only.

Description

GLP-1
Receptor target
≥99%
HPLC-verified purity
4114
Molar mass (g/mol)
10 / 20 mg
Vial sizes available
Molecular Breakdown

Semaglutide — GLP-1 receptor agonist

Semaglutide is a synthetic, acylated analog of human glucagon-like peptide-1 (GLP-1) — a 31-amino-acid peptide engineered for a long half-life. It is the most widely studied single GLP-1 receptor agonist in metabolic research. Supplied as a lyophilized research peptide in 10 mg and 20 mg vials.

Rx

Semaglutide

Aliases: GLP-1 analog · GLP-1 receptor agonist · acylated GLP-1(7-37) analog

A long-acting, fatty-acid-modified analog of human GLP-1 studied in preclinical models of glucoregulation and energy metabolism.

TypeGLP-1 receptor agonist (acylated peptide analog)
Structure31-amino-acid GLP-1 analog, C18-diacid modified
FormulaC₁₈₇H₂₉₁N₄₅O₅₉
Molar mass≈4113.6 g/mol
CAS910463-68-2
Vial sizes10 mg · 20 mg
ReferencePubChem ↗

Storage: Lyophilized, store at −20°C, protected from light. Reconstitute with bacteriostatic water; keep reconstituted vials at 2–8°C.

Research Focus — Metabolic / Incretin

In the published literature, Semaglutide is characterized as a selective GLP-1 receptor agonist and studied in preclinical models of insulin secretion, glucoregulation, appetite signaling, and energy metabolism. It is the reference “single agonist” against which dual (GLP-1/GIP) and triple agonists are compared.

GLP-1 receptor agonismInsulin-secretion modelsGlucoregulation researchAppetite / satiety signalingEnergy-metabolism modelsBody-weight regulation

Selected Research

Published literature

Peer-reviewed studies of the compound itself. Provided for scientific reference; they do not describe this product or authorize any human use.

Lau J, et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. J Med Chem. 2015;58(18):7370–7380. PMID 26308095 ↗
Browse the full literature: Semaglutide studies on PubMed ↗

Citations are provided for scientific reference only and do not constitute claims about this product.

🧪

Backed by a lot-matched Certificate of Analysis

Every Semaglutide order is tied to a COA for the exact lot in your vial — identity and ≥99% purity confirmed by HPLC / mass spectrometry.

View COAs →

⚠️ For Research Use Only. Sold exclusively as reference material for in-vitro laboratory and educational research. Not evaluated by the FDA; not for human or veterinary use, consumption, diagnosis, treatment, or to prevent any disease.

Additional information

Weight 0.2 lbs
Dimensions 0.75 × 1.5 in
Size

10mg, 20mg

Related products